John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Qualcomm
QCOM
$169B
| $12.6M | 0.06% |
181,330
-373,550
| -67% | -$26.3M |
|
|
DCH
402
Dauch Corp
DCH
$1.63B
| $12.3M | 0.06% |
476,944
+202,703
| +74% | +$4.98M |
|
|
MFA
403
MFA Financial
MFA
$901M
| $12.3M | 0.06% |
390,568
+97,189
| +33% | +$3.08M |
|
|
BNCL
404
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $12.3M | 0.06% |
1,087,608
+943,819
| +656% | +$10.5M |
|
405
PUT
Pfizer
PFE
$160B
| $12.2M | 0.06% |
+371,008
| New | +$11.8M |
|
406
Take-Two Interactive
TTWO
$44.8B
| $12.2M | 0.06% |
+477,701
| New | +$13M |
|
|
CXP
407
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $12.1M | 0.06% |
449,389
+39,448
| +10% | +$1.01M |
|
|
SPN
408
DELISTED
Superior Energy Services, Inc.
SPN
| $12.1M | 0.06% |
54,214
+9,845
| +22% | +$2.04M |
|
|
CBM
409
DELISTED
Cambrex Corporation
CBM
| $12.1M | 0.06% |
305,392
+128,231
| +72% | +$3.79M |
|
410
Zions Bancorporation
ZION
$9.95B
| $12M | 0.06% |
445,908
-1,044,353
| -70% | -$27.3M |
|
411
First Solar
FSLR
$23B
| $12M | 0.06% |
201,070
+192,570
| +2,266% | +$9.89M |
|
412
Kirby Corp
KEX
$7.39B
| $12M | 0.06% |
159,856
-25,883
| -14% | -$2M |
|
413
Charles River Laboratories
CRL
$14.1B
| $12M | 0.06% |
151,189
+131,934
| +685% | +$9.73M |
|
|
HMHC
414
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $12M | 0.06% |
508,994
+46,789
| +10% | +$963K |
|
|
EQY
415
DELISTED
Equity One
EQY
| $11.9M | 0.06% |
446,378
+188,873
| +73% | +$5.08M |
|
|
MRC
416
DELISTED
MRC Global
MRC
| $11.9M | 0.06% |
1,003,923
+149,640
| +18% | +$1.87M |
|
417
Trip.com Group
TCOM
$29B
| $11.9M | 0.06% |
+405,024
| New | +$9.78M |
|
418
AptarGroup
ATR
$8.57B
| $11.8M | 0.06% |
+186,331
| New | +$12M |
|
|
OA
419
DELISTED
Orbital ATK, Inc.
OA
| $11.8M | 0.06% |
154,369
+121,548
| +370% | +$11.5M |
|
420
KBR
KBR
$4.86B
| $11.8M | 0.06% |
816,407
-535,593
| -40% | -$8.71M |
|
421
News Corp Class A
NWSA
$16.4B
| $11.8M | 0.06% |
738,381
-1,996,827
| -73% | -$32.3M |
|
422
Vanguard Real Estate ETF
VNQ
$39.1B
| $11.8M | 0.06% |
140,600
+104,600
| +291% | +$8.88M |
|
|
PF
423
DELISTED
Pinnacle Foods, Inc.
PF
| $11.8M | 0.06% |
289,000
-360,962
| -56% | -$13.4M |
|
|
BECN
424
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $11.8M | 0.05% |
375,837
+193,638
| +106% | +$5.31M |
|
|
STR
425
DELISTED
QUESTAR CORP
STR
| $11.7M | 0.05% |
+492,271
| New | +$12M |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.